This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
between 18 and 120
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of blood from patients with breast cancer in the laboratory may help doctors identify and learn more about biomarkers related to tamoxifen resistance. PURPOSE: This laboratory study is looking at tamoxifen resistance in women with stage I, stage II, stage IIIA, or stage IIIB breast cancer.

Provided treatments

  • Drug: tamoxifen citrate
  • Genetic: gene expression analysis
  • Genetic: protein expression analysis
  • Other: immunoenzyme technique
  • Other: laboratory biomarker analysis
Tris trial is registered with FDA with number: NCT00899197. The sponsor of the trial is Wake Forest University Health Sciences and it is looking for 2 volunteers for the current phase.
Official trial title:
Tamoxifen Resistance in Breast Cancer